1. Editorial

   • Jan H. Beumer

   Editorial 24 January 2020 Pages: 1 - 1

   

2. Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin

   • Liwei Meng
   • Liming Huang
   • Wei Zhang

   Review Article 03 August 2019 Pages: 3 - 7

   

3. Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development

   • Gesuino Angius
   • Silverio Tomao
   • Federica Tomao

   Review Article 11 September 2019 Pages: 9 - 20

   

4. Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia

   • Susanna E. Medellin-Garibay
   • Nadia Hernández-Villa
   • Silvia Romano-Moreno

   Original Article 31 October 2019 Pages: 21 - 31

   

5. The secondary metabolites produced by Lactobacillus plantarum downregulate BCL-2 and BUFFY genes on breast cancer cell line and model organism Drosophila melanogaster: molecular docking approach

   • Melih Sentürk
   • Fahriye Ercan
   • Serap Yalcin

   Original Article 31 October 2019 Pages: 33 - 45

   

6. Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)

   • Bahareh Kashani
   • Zahra Zandi
   • Seyed H. Ghaffari

   Original Article 30 November 2019 Pages: 47 - 59

   

7. Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials

   • Zhou Xu
   • Feng Luo
   • Ling-quan Kong

   Original Article 19 November 2019 Pages: 61 - 67

   

8. Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma

   • Juanfang Liu
   • Shanshan Xie
   • Xinwei Han

   Original Article 07 December 2019 Pages: 69 - 76

   

9. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer

   • Yang Zhao
   • Lijuan Wei
   • Fangxuan Li

   Original Article 16 December 2019 Pages: 77 - 93

   

10. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia

    • Hui Li
    • Qiong Xu
    • Jianxin Li

    Original Article 01 November 2019 Pages: 95 - 103

    

11. Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy

    • Luigi Rossi
    • Monica Verrico
    • Federica Tomao

    Original Article 21 November 2019 Pages: 105 - 111

12. Dose-finding study of modified FLOT (mFLOT) regimen as first-line treatment in Chinese patients with metastatic adenocarcinoma of stomach

    • Chenfei Zhou
    • Tao Ma
    • Jun Zhang

    Original Article 05 November 2019 Pages: 113 - 119

    

13. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors

    • Anne Schett
    • Sacha I. Rothschild
    • Markus Joerger

    Original Article 19 November 2019 Pages: 121 - 131

    

14. Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma

    • Melissa J. Garwood
    • Eliza A. Hawkes
    • Geoffrey Chong

    Original Article 17 December 2019 Pages: 133 - 140

    

15. Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development

    • Pawat Pattarawat
    • Shelby Wallace
    • Hwa-Chain Robert Wang

    Original Article 21 December 2019 Pages: 141 - 152

    

16. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan

    • Mansour Poorebrahim
    • Solmaz Sadeghi
    • Ladan Teimoori-Toolabi

    Original Article 28 November 2019 Pages: 153 - 171

    

17. Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors

    • Su Young Jung
    • Ji Seob Yug
    • Jangik I. Lee

    Original Article 30 October 2019 Pages: 173 - 183

    

18. Discovery of hPRDX5-based peptide inhibitors blocking PD-1/PD-L1 interaction through in silico proteolysis and rational design

    • Sen Zou
    • Juanjuan Liu
    • Zhaoyong Yang

    Original Article 19 November 2019 Pages: 185 - 193

    

19. Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation

    • Haidi Huang
    • Xin Wang
    • Wanglin Jiang

    Original Article 07 December 2019 Pages: 195 - 204

    

20. Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer

    • Liang Huang
    • Xiaojia Wang
    • Zhimin Shao

    Original Article Open access 14 December 2019 Pages: 205 - 215

    

21. Multicenter phase II study of SOX plus trastuzumab for patients with HER2⁺ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B

    • Satoshi Yuki
    • Katsunori Shinozaki
    • Masaki Mori

    Clinical Trial Report 25 November 2019 Pages: 217 - 223

    

22. PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity

    • Shaun D. Fontaine
    • Angelo D. Santi
    • Daniel V. Santi

    Short Communication 09 November 2019 Pages: 225 - 229

    

23. A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions

    • Nikki de Rouw
    • Sabine Visser
    • Rob ter Heine

    Short Communication Open access 18 December 2019 Pages: 231 - 235

    

24. Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation

    • Ou Yamaguchi
    • Kyoichi Kaira
    • Hiroshi Kagamu

    Correction 08 November 2019 Pages: 237 - 239

    

25. Acknowledgement of reviewers 2019

    Acknowledgement 16 December 2019 Pages: 241 - 244